News
Work has begun in the UK on developing new tests that will spot if someone has “fat genes”. The project, which seeks to ...
6h
Futurism on MSNEli Lilly's New Weight Loss Drug May Have the Worst Name in Pharmaceutical HistoryEli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...
The head of Zealand Pharma has called its $5.3bn partnership with Roche to commercialise an obesity drug with fewer ...
If you value the S&P 500 on earnings, its price-to-earnings ratio of 28 is also significantly above its historical norms. The Vanguard FTSE Developed Markets ETF trades at 15.5 times earnings today, a ...
7h
Just Short of Crazy on MSNChinese Factory Produces Top Tier Hermes Bags At 5% Of The Retail PriceFactories in China Factories in China are posting content on social platforms about the true cost to produce a luxury He ...
Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results